Early Alert: Convenience Kit Issue from American Contract Systems
The FDA issued an alert regarding Namic RA syringes included in convenience kits from American Contract Systems, noting that the syringe adaptor may unwind during use. This mechanical failure can result in loose connections or complete disconnections during clinical procedures.
Healthcare facilities using American Contract Systems convenience kits, specifically those containing Namic RA syringes, and clinical staff involved in procedures requiring these syringes.
A disconnection in this type of device represents a significant clinical risk, as the source indicates potential for infection, blood loss, and air embolism. From a regulatory perspective, this alert suggests a critical failure in component performance that may necessitate rapid inventory audits and post-market surveillance reporting by affected entities.
Identify and quarantine affected convenience kits containing Namic RA syringes. Prepare for clinical reporting of adverse events related to disconnection, such as air embolisms or infections, and verify the integrity of syringe adapters before any use in clinical settings.
The adaptor on Namic RA syringes may unwind during use. The resulting loose connection or disconnection may lead to infection, blood loss, or air embolism.
Open in openFDA / FDA.gov